Anzeige
Mehr »
Donnerstag, 06.11.2025 - Börsentäglich über 12.000 News
Kanadas neuer Technologie-Champion: Telescope erhält bis zu 3,36 Mio. $ staatliche Förderung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
351 Leser
Artikel bewerten:
(1)

Experion Holdings Ltd.: Experion Announces Leadership Change

VANCOUVER, BC / ACCESSWIRE / January 6, 2020 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announces the departure of Chief Executive Officer and director, Jay Garnett, effective January 3, 2020. Experion's board of directors (the "Board") would like to thank Mr. Garnett for his service.

The Board has appointed Mr. Jarrett Malnarich as Chief Executive Officer and a director of the Corporation effective immediately. Mr. Malnarich has been the Chief Operating Officer of Experion since October 2017 and served as Interim Chief Executive Officer of Experion from March 2018 to October 15, 2018.

Over the course of his career, Mr. Malnarich has been an executive, director and advisor with various public and private companies in the agriculture, biotechnology and cannabis sector. He has secured funding, managed various mergers and acquisitions, and has directly helped numerous cannabis companies in Canada and internationally with licensing, building and executing business plans.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including adult-use, wellness and therapeutic, and medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "EXP", on the OTCQB Venture under the symbol "EXPFF" and on the Frankfurt Stock Exchange under the symbol "MB31".

For further information, please visit the Company's website www.experionwellness.com or join our Global Investor Forum on 8020 http://connects.company/ExperionEXP where you can read all press releases or contact Investor Relations, Phone: (604) 340-3621, Email: IR@experionwellness.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.



View source version on accesswire.com:
https://www.accesswire.com/572034/Experion-Announces-Leadership-Change

© 2020 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.